alexa Sourcing Generic Formulations & OTC Drugs From Indian Pharmaceutical Manufacturers: A GMP Fiasco Waiting To Happen? | 13821
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

3rd International Conference on Pharmaceutical Regulatory Affairs

Ram Balani
Accepted Abstracts: Pharmaceut Reg Affairs
DOI: 10.4172/2167-7689.S1.012
Abstract
According to the Generics Pharmaceutical Healthcare Association (GPhA) , ?Every other day, generics save consumers and the US Healthcare System, $ 1 Billion US dollars ! Did you know 80% of drug prescriptions in the US are written for generic drugs? Out of this 80%, one (1) out of every four (4) or 25% of US generic drugs comes from India and though India is 3rd in terms of volume in the drug industry, it ranks a low 14th in dollar terms, i.e. a testament to the efficient and very competitive, LOWCOST Indian drug manufacturing industry. India relies heavily on generics domestically as well and the generics drug Market in India is projected to grow at a CAGR of around 17 % between 2010-11 and 2012 and 2015. In his presentation, Ram Balani will focus on opportunities and challenges to sourcing generic formulations or OTC drugs from India with focus on GMP manufacturing regulatory compliance. India claims to have the most US FDA approved drug manufacturing yet recent negative events point to deficiencies with global GMP standards due to various reasons that include its tolerant work culture with very ?forgiving? best practices and lack of appreciation that GMP is a constant mind-set instead of a mere series of short-term rules you can check-off from a list, etc. Ram Balani will trace with how India became the 800-lb pharma industry ?gorilla? specially with generics, discuss topics on how to navigate the Indian drug manufacturer supply chain channels, cover the two (2) types of GMP deficiencies that include lack of enforcement or training to deliberate criminal intent with counterfeits, etc. New US FDA initiatives to safeguard American pharmaceutical supply chain will also be covered including GDUFA, FDASIA, etc and how that will affect the Indian pharmaceutical industry with US markets. Ram Balani will present strategies & options to challenges with sourcing from India as the country continues to evolve it?s role as ?pharmacy to the world? and will briefly discuss the changing biotech/biologics focus of Indian pharmaceutical industry.
Biography
Ram Balani has a wide range of experience in various life sciences areas that includes pharmaceuticals, medical research, real-time IT and software development, LIMS, robotics and automated retrieval systems specifically. He is also well versed with US FDA, MHRA and Health Canada pharmaceutical industry regulatory compliance with manufacturing and sourcing specifically. FDASmart, the latest company he founded, provides pharmaceutical regulatory compliance consulting & manufacturing/supply chain intelligence to assist emerging regions create new markets. In U.S. Ram actively assists SMEs (Small/Medium Enterprises) with sourcing drugs (generics, OTCs) or contract manufacturing services from emerging regions including China, India, Bangladesh etc, For emerging regions, FDASmart assist with ANDA partnering search, in-licensing, out-licensing, etc.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7